Charoenngam N (2026). [PMID: 41685558](https://pubmed.ncbi.nlm.nih.gov/41685558/). *Endocr Relat Cancer*. [Review / Meta-Analysis]
Huo Q (2026). [PMID: 41620782](https://pubmed.ncbi.nlm.nih.gov/41620782/). *Eur J Med Res*. [Basic Science / Preclinical]
Schuster AK (2025). [PMID: 41143480](https://pubmed.ncbi.nlm.nih.gov/41143480/). *Transl Vis Sci Technol*. [Epidemiology / Natural History]
Ankathatti Narayanaswamy I (2025). [PMID: 39476301](https://pubmed.ncbi.nlm.nih.gov/39476301/). *Clin Transl Oncol*. [Review / Meta-Analysis]
Sondel PM (2025). [PMID: 41176314](https://pubmed.ncbi.nlm.nih.gov/41176314/). *J Immunother Cancer*. [Review / Meta-Analysis]
Clark CJ (2025). [PMID: 40668547](https://pubmed.ncbi.nlm.nih.gov/40668547/). *Cancer Epidemiol Biomarkers Prev*. [Epidemiology / Natural History]
Abdelhafeez A (2025). [PMID: 40916057](https://pubmed.ncbi.nlm.nih.gov/40916057/). *Pediatr Blood Cancer*. [Clinical Trial Publication]
Zirngibl F (2025). [PMID: 39788293](https://pubmed.ncbi.nlm.nih.gov/39788293/). *Transplant Cell Ther*. [Clinical Trial Publication]
Schuster AK (2025). [PMID: 39846480](https://pubmed.ncbi.nlm.nih.gov/39846480/). *Acta Ophthalmol*. [Epidemiology / Natural History]
Wens FSPL (2025). [PMID: 40441488](https://pubmed.ncbi.nlm.nih.gov/40441488/). *Radiother Oncol*. [Review / Meta-Analysis]
